Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2017 Mar 22

PMID 28321772

Citations 54

Authors

Michelle D Williams

Affiliations

Soon will be listed here.

Abstract

Paragangliomas (PGL) develop from the parasympathetic system in the head and neck (HN) and arise primarily in four distinct areas: Carotid body, vagal, middle ear, and larynx. Globally, the diagnosis and morphologic features are the same regardless of anatomic site, however the incidence, frequency of genetic alterations/syndromes and differential diagnosis vary. It is now recognized that nearly 40% of all HN PGLs are hereditary, including a significant subset without a known family history. Now pathologists are central to the evaluation for diagnosis and further management of patients with HNPGLs. Specifically, SDHB immunohistochemical evaluation is an excellent screening tool to detect tumors with alterations in the SDH family of genes that represent the majority of hereditary cases in HNPGL. Similarly, SDHB immunohistochemical analysis allows for screening of PGL syndrome associated tumors (gastrointestinal stromal tumor (GIST), renal cell carcinoma (RCC), and pituitary adenomas) that have now been linked by their overlapping gene alterations. Awareness of the spectrum of these syndromes, and their associated tumors, positions the pathologist to augment patient care and surveillance.

Citing Articles

Optimal Screening for Hereditary Head and Neck Paraganglioma in Asymptomatic SDHx Variant Carriers in the Netherlands.

Heesters A, Tops C, Potjer T, Corssmit E, Bayley J, Hensen E J Neurol Surg B Skull Base. 2025; 86(1):1-5.

PMID: 39881751 PMC: 11774608. DOI: 10.1055/s-0044-1781438.

Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis.

Canu L, Zanatta L, Sparano C, Santoro R, Mannelli G, Zamengo S Endocrine. 2025; .

PMID: 39864047 DOI: 10.1007/s12020-025-04167-1.

Identification of a pathogenic SDHD mutation in a Chinese family with hereditary head and neck paraganglioma: implications for genetic counseling and management.

Wang P, Gao L, Zhang W, Guo R, Xia Y World J Surg Oncol. 2025; 23(1):4.

PMID: 39754145 PMC: 11697643. DOI: 10.1186/s12957-024-03641-w.

Laryngeal Paraganglioma with Neck Metastasis.

Tripuraneni S, Gera S, Patibandla A, Rangisetty A Indian J Otolaryngol Head Neck Surg. 2024; 76(5):4648-4652.

PMID: 39376327 PMC: 11455980. DOI: 10.1007/s12070-024-04734-4.

[Advance in HIF expression and immune microenvironment in pseudohypoxic HNPGL].

Zhang B, Lou Z, Wang J, Hu Y, Chen Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(9):823-829.

PMID: 39193740 PMC: 11839587. DOI: 10.13201/j.issn.2096-7993.2024.09.009.

References

Gill A, Benn D, Chou A, Clarkson A, Muljono A, Meyer-Rochow G . Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol. 2010; 41(6):805-14. DOI: 10.1016/j.humpath.2009.12.005. View

Dwight T, Mann K, Benn D, Robinson B, McKelvie P, Gill A . Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. J Clin Endocrinol Metab. 2013; 98(6):E1103-8. DOI: 10.1210/jc.2013-1400. View

Myssiorek D, Rinaldo A, Barnes L, Ferlito A . Laryngeal paraganglioma: an updated critical review. Acta Otolaryngol. 2004; 124(9):995-9. DOI: 10.1080/00016480410017576. View

Miettinen M, Wang Z, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J . Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol. 2011; 35(11):1712-21. PMC: 3193596. DOI: 10.1097/PAS.0b013e3182260752. View

Menara M, Oudijk L, Badoual C, Bertherat J, Lepoutre-Lussey C, Amar L . SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma. J Clin Endocrinol Metab. 2014; 100(2):E287-91. DOI: 10.1210/jc.2014-1870. View

Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke H, Glasker S . Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo). 2012; 67 Suppl 1:19-28. PMC: 3328838. DOI: 10.6061/clinics/2012(sup01)05. View

Fishbein L . Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment. Hematol Oncol Clin North Am. 2015; 30(1):135-50. DOI: 10.1016/j.hoc.2015.09.006. View

Toledo R, Burnichon N, Cascon A, Benn D, Bayley J, Welander J . Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2016; 13(4):233-247. DOI: 10.1038/nrendo.2016.185. View

Barnes L . Paragangliomas of the larynx. J Laryngol Otol. 1993; 107(7):664. DOI: 10.1017/s0022215100124041. View

10.

Ferlito A, Milroy C, Wenig B, Barnes L, Silver C . Laryngeal paraganglioma versus atypical carcinoid tumor. Ann Otol Rhinol Laryngol. 1995; 104(1):78-83. DOI: 10.1177/000348949510400113. View

11.

Carlson M, Sweeney A, Pelosi S, Wanna G, Glasscock 3rd M, Haynes D . Glomus tympanicum: a review of 115 cases over 4 decades. Otolaryngol Head Neck Surg. 2014; 152(1):136-42. DOI: 10.1177/0194599814555849. View

12.

GLOOR F . [A very unusual case of tumor of the larynx. Unexpected anatomopathologic diagnosis]. Ann Otolaryngol Chir Cervicofac. 1968; 85(4):329-35. View

13.

Benn D, Robinson B, Clifton-Bligh R . 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer. 2015; 22(4):T91-103. PMC: 4532956. DOI: 10.1530/ERC-15-0268. View

14.

Gill A, Pachter N, Chou A, Young B, Clarkson A, Tucker K . Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol. 2011; 35(10):1578-85. DOI: 10.1097/PAS.0b013e318227e7f4. View

15.

Sajid M, Hamilton G, BAKER D . A multicenter review of carotid body tumour management. Eur J Vasc Endovasc Surg. 2007; 34(2):127-30. DOI: 10.1016/j.ejvs.2007.01.015. View

16.

Baysal B, Willett-Brozick J, Lawrence E, Drovdlic C, Savul S, McLeod D . Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet. 2002; 39(3):178-83. PMC: 1735061. DOI: 10.1136/jmg.39.3.178. View

17.

Baysal B, Maher E . 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Endocr Relat Cancer. 2015; 22(4):T71-82. DOI: 10.1530/ERC-15-0226. View

18.

Amato B, Bianco T, Compagna R, Siano M, Esposito G, Buffone G . Surgical resection of carotid body paragangliomas: 10 years of experience. Am J Surg. 2013; 207(2):293-8. DOI: 10.1016/j.amjsurg.2013.06.002. View

19.

Haller F, Moskalev E, Faucz F, Barthelmess S, Wiemann S, Bieg M . Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer. 2014; 21(4):567-77. PMC: 4722532. DOI: 10.1530/ERC-14-0254. View

20.

Pacak K, Wimalawansa S . Pheochromocytoma and paraganglioma. Endocr Pract. 2015; 21(4):406-12. DOI: 10.4158/EP14481.RA. View